Sangamo Therapeutics Postpones First Quarter 2025 Conference Call to Later the Same Day

RICHMOND, Calif.--(BUSINESS WIRE)--May 12, 2025-- 

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the first quarter earnings call originally scheduled for 4:30p.m. Eastern on Monday, May 12 will be postponed to 6:30p.m. Eastern on Monday, May 12, 2025.

The registration and access link previously provided remains the same.

Participants should register for, and access, the call using this link. While not required, it is recommended to join 10 minutes prior to the event start. Once registered, participants will be given the option to either dial into the call with the number and unique passcode provided, or to use the dial-out option to connect their phone instantly. The link to access the live webcast can also be found on the Sangamo Therapeutics website in the Investors and Media section under Events.

A replay will be available following the conference call, accessible under Events.

About Sangamo Therapeutics

Sangamo Therapeutics is a genomic medicine company dedicated to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases who do not have adequate or any treatment options. Sangamo believes that its zinc finger epigenetic regulators are ideally suited to potentially address devastating neurological disorders and that its capsid discovery platform can expand delivery beyond currently available intrathecal delivery capsids, including in the central nervous system. Sangamo's pipeline also includes multiple partnered programs and programs with opportunities for partnership and investment. To learn more, visit www.sangamo.com and connect with us on LinkedIn and X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250512813982/en/

 
    CONTACT:    Investor Relations 

Louise Wilkie

ir@sangamo.com

Media Inquiries

Melinda Hutcheon

media@sangamo.com

(END) Dow Jones Newswires

May 12, 2025 16:45 ET (20:45 GMT)